NASDAQ:SPRC - Nasdaq - IL0010951403 - Common Stock - Currency: USD
0.2826
+0.01 (+4.43%)
The current stock price of SPRC is 0.2826 USD. In the past month the price decreased by -16.64%. In the past year, price decreased by -77.02%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
MRK | MERCK & CO. INC. | 10.21 | 196.28B | ||
PFE | PFIZER INC | 7.12 | 125.57B | ||
SNY | SANOFI-ADR | 11.41 | 124.61B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
GSK | GSK PLC-SPON ADR | 8.3 | 72.81B | ||
ZTS | ZOETIS INC | 25.11 | 66.32B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.30B |
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
SCISPARC LTD
20 Raul Wallenberg Street, Tower A
TEL AVIV-YAFO IL
Employees: 3
Company Website: https://scisparc.com/
Investor Relations: https://investor.scisparc.com/
Phone: 97236103100
The current stock price of SPRC is 0.2826 USD. The price increased by 4.43% in the last trading session.
The exchange symbol of SCISPARC LTD is SPRC and it is listed on the Nasdaq exchange.
SPRC stock is listed on the Nasdaq exchange.
SCISPARC LTD (SPRC) has a market capitalization of 4.34M USD. This makes SPRC a Nano Cap stock.
SCISPARC LTD (SPRC) currently has 3 employees.
SCISPARC LTD (SPRC) has a support level at 0.21 and a resistance level at 0.28. Check the full technical report for a detailed analysis of SPRC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SPRC does not pay a dividend.
SCISPARC LTD (SPRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.81).
The outstanding short interest for SCISPARC LTD (SPRC) is 0.44% of its float. Check the ownership tab for more information on the SPRC short interest.
ChartMill assigns a fundamental rating of 2 / 10 to SPRC. The financial health of SPRC is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SPRC reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS increased by 36.22% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -46.15% | ||
ROE | -67.77% | ||
Debt/Equity | 0 |